Search research articles
Contact Us
Filters
Showing results (11-20 of 14) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 14 results.
Neurogastroenterology and Motility
|
September 3, 2013
Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they?
N de Bortoli, I Martinucci, E Savarino, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus
|
September 13, 2014
Lower pH values of weakly acidic refluxes as determinants of heartburn perception in gastroesophageal reflux disease patients with normal esophageal acid exposure
N de Bortoli, I Martinucci, E Savarino, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus
|
December 18, 2014
Voluntary and controlled weight loss can reduce symptoms and proton pump inhibitor use and dosage in patients with gastroesophageal reflux disease: a comparative study
N de Bortoli, G Guidi, I Martinucci, et al.
ESMO Open
|
July 6, 2024
A 1-year follow-up study on checkpoint inhibitor-induced colitis: results from a European consortium
M V Lenti, D G Ribaldone, F Borrelli de Andreis, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 14) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 14 results.
Neurogastroenterology and Motility
|
September 3, 2013
Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they?
N de Bortoli, I Martinucci, E Savarino, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus
|
September 13, 2014
Lower pH values of weakly acidic refluxes as determinants of heartburn perception in gastroesophageal reflux disease patients with normal esophageal acid exposure
N de Bortoli, I Martinucci, E Savarino, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus
|
December 18, 2014
Voluntary and controlled weight loss can reduce symptoms and proton pump inhibitor use and dosage in patients with gastroesophageal reflux disease: a comparative study
N de Bortoli, G Guidi, I Martinucci, et al.
ESMO Open
|
July 6, 2024
A 1-year follow-up study on checkpoint inhibitor-induced colitis: results from a European consortium
M V Lenti, D G Ribaldone, F Borrelli de Andreis, et al.
Page
of 2